Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Birch pollen extract - Stallergenes Greer plc

Drug Profile

Birch pollen extract - Stallergenes Greer plc

Alternative Names: Bet v 1; Bet v 1a; Oralair Bet V 1 recombinant allergen; Oralair Birch; rBet v 1; Staller (Birch); Staloral Birch

Latest Information Update: 17 Aug 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Stallergenes SA
  • Developer Endo International; Stallergenes Greer plc; Stallergenes SA
  • Class Allergens; Antiallergics; Peptide vaccines; Peptides; Skin disorder therapies; Tree pollen allergy immunotherapies
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Seasonal allergic rhinitis

Most Recent Events

  • 17 Aug 2019 No development reported - Phase-II for Seasonal allergic rhinitis in Russia, Denmark, Finland, Sweden (Sublingual)
  • 17 Aug 2019 No development reported - Phase-III for Seasonal allergic rhinitis in Denmark, Czech Republic, Estonia, Finland, France, Germany, Poland, Slovakia, Sweden, Latvia, Latvia, Lithuania (Sublingual)
  • 24 Jun 2018 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top